| AA | arachidonic acid |
| ACEi | angiotensin converting enzyme inhibitor |
| ACE | angiotensin converting enzyme |
| ACE2 | angiotensin converting enzyme type 2 |
| ACF | aorto-caval fistula |
| ANG II | angiotensin II |
| ANG 1-7 | angiotensin 1-7 |
| AT1 | angiotensin II type 1 receptor |
| AT2 | angiotensin II type 2 receptor |
| CYP | cytochrome P-450 enzyme |
| CYP2C23 | cytochrome P-450 enzyme subfamily 2C23 |
| CYP4A1 | cytochrome P-450 enzyme subfamily 4A1 |
| DHETEs | dihydroxyeicosatrienoic acids (DHETEs) |
| DOX | doxorubicin |
| ECE-1 | endothelin-converting enzyme type 1 |
| EETs | epoxyeicosatrienoic acids |
| ETA | endothelin type A receptor |
| ETB | endothelin type B receptor |
| ET-1 | endothelin-1 |
| HanSD | normotensive, transgene-negative, Hannover Sprague–Dawley rats |
| HF | heart failure |
| HFrEF | heart failure with reduced ejection fraction |
| IKEM | Institute for Clinical and Experimental Medicine |
| MI | myocardial infarction |
| mRNA | messenger ribonucleic acid |
| NE | norepinephrine |
| RAAS | renin-angiotensin-aldosterone system |
| ROS | reactive oxygen species |
| RSNA | renal sympathetic nerve activity |
| sEH | soluble epoxide hydrolase |
| TGR | Ren2 renin transgenic, hypertensive rats |
| 20-HETE | 20-hydroxyeicosatrienoic acid |